Thomas Ehlin News Today

/PRNewswire/ -- The shareholders in Swedish Orphan Biovitrum AB (publ) (Sobi®) Reg. No. 556038-9321, are hereby summoned to the Annual General Meeting (the...

The following members have been appointed to XVIVO Perfusion’s nomination committee for the 2024 annual general meeting:Henrik Blomquist, appointed by Bure Equity ABFredrik Stenkil, appointed by...

CAVOTECS NOMINATION COMMITTEE PROPOSALS TO THE BOARD OF DIRECTORS FOR THE ANNUAL GENERAL MEETING 2023 AND MOTIVATED OPINION REGARDING THE PROPOSALS ... | April 27, 2023

CORPORATE GOVERNANCE REPORT 2023 Since Cavotec is a Swiss company listed on Nasdaq Stockholm, the corporate governance of Cavotec is based on... | April 27, 2023

The shareholders in Swedish Orphan Biovitrum AB Reg. No. 556038-9321, are hereby summoned to the Annual General Meeting , to be held on Tuesday, 9 May 2023 at 15.00 at IVA Konferenscenter, Grev... | March 30, 2023

N.B. This is an unofficial translation of the Swedish original wording. In case of differences between the English translation and the Swedish original, the Swedish text shall... | March 23, 2023

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL) (FRA:3XV) XVIVO Perfusion AB (publ) (the "Company"), reg. no. 556561-0424, with its registered office in Gothenburg, gives notice of the the Annual General Meeting to be held on Tuesday 25 April 2023...

Notice to attend the Annual General Meeting in XVIVO Perfusion AB (publ) ...

GOTHENBURG, SE / ACCESSWIRE / March 23, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL) (FRA:3XV) XVIVO Perfusion AB (publ) (the "Company"), reg. no. 556561-0424, with its registered office in Gothenburg

GOTHENBURG, SE / ACCESSWIRE / September 30, 2022 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)The following members have been appointed to XVIVO Perfusion's nomination committee for the 2023 annual